
One of the most groundbreaking developments in modern oncology is CAR T therapy, a revolutionary approach that harnesses the power of a patient’s own immune system to fight cancer. This method involves genetically modifying T cells to express chimeric antigen receptors (CARs), allowing them to specifically target and destroy cancer cells. While CAR T therapy has shown remarkable success in treating hematologic malignancies such as leukemia and lymphoma, researchers are now exploring ways to enhance its efficacy using stem cell-derived approaches. By integrating stem cell technology into CAR T development, scientists aim to improve treatment scalability, reduce side effects, and expand applications to solid tumors.